$PCT
PureCycle Technologies, Inc. Stock $pct

$pct Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000183003322000028 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$14.75M	$7.624M
YoY Change	93.43%	515.83%
% of Gross Profit
Research & Development	$339.0K	$547.0K
YoY Change	-38.03%	57.18%
% of Gross Profit
Depreciation & Amortization	$818.0K	$490.0K
YoY Change	66.94%	5.38%
% of Gross Profit
Operating Expenses	$19.13M	$10.30M
YoY Change	85.75%	215.11%
Operating Profit
YoY Change
Interest Expense	$444.0K	$2.043M
YoY Change	-78.27%	247.45%
% of Operating Profit
Other Income/Expense, Net	-$6.298M	-$15.77M
YoY Change	-60.07%	1117.99%
Pretax Income	-$25.43M	-$30.12M
YoY Change	-15.56%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$25.43M	-$26.07M
YoY Change	-2.46%	471.3%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.19	-$0.51
Diluted Earnings Per Share	-$0.19	-$0.51
COMMON SHARES
Basic Shares Outstanding	133.2M shares	51.22M shares
Diluted Shares Outstanding	133.2M shares	51.22M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$418.0M	$252.5M
YoY Change	65.53%	252400.0%
Cash & Equivalents	$198.2M	$252.5M
Short-Term Investments	$219.8M
Other Short-Term Assets	$103.4M	$6.800M
YoY Change	1420.6%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$521.3M	$259.3M
YoY Change	101.02%	259240.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$266.3M	$108.4M
YoY Change	145.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$97.19M	$317.5M
YoY Change	-69.39%	317400.0%
Total Long-Term Assets	$377.4M	$425.9M
YoY Change	-11.38%	425823.0%
TOTAL ASSETS
Total Short-Term Assets	$521.3M	$259.3M
Total Long-Term Assets	$377.4M	$425.9M
Total Assets	$898.8M	$685.3M
YoY Change	31.16%	342531.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.841M	$1.481M
YoY Change	24.31%
Accrued Expenses	$19.33M	$18.45M
YoY Change	4.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$300.0K
YoY Change	-100.0%	50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$27.30M	$30.63M
YoY Change	-10.87%	15213.0%
LONG-TERM LIABILITIES
Long-Term Debt	$232.8M	$289.0M
YoY Change	-19.46%
Other Long-Term Liabilities	$1.106M	$24.30M
YoY Change	-95.45%
Total Long-Term Liabilities	$1.106M	$313.3M
YoY Change	-99.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$27.30M	$30.63M
Total Long-Term Liabilities	$1.106M	$313.3M
Total Liabilities	$335.6M	$343.9M
YoY Change	-2.42%	171858.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.2M	-$114.2M
YoY Change	60.42%
Common Stock	$163.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$563.2M	$349.2M
YoY Change
Total Liabilities & Shareholders Equity	$898.8M	$685.3M
YoY Change	31.16%	342531.5%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$25.43M	-$26.07M
YoY Change	-2.46%	471.3%
Depreciation, Depletion And Amortization	$818.0K	$490.0K
YoY Change	66.94%	5.38%
Cash From Operating Activities	-$16.92M	-$20.57M
YoY Change	-17.72%	318.13%
INVESTING ACTIVITIES
Capital Expenditures	-$52.18M	-$33.89M
YoY Change	53.96%
Acquisitions
YoY Change
Other Investing Activities	-$52.88M
YoY Change
Cash From Investing Activities	-$105.1M	-$33.89M
YoY Change	209.99%	4341.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$205.0M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$248.2M	$294.0M
YoY Change	-15.58%	3302.03%
NET CHANGE
Cash From Operating Activities	-$16.92M	-$20.57M
Cash From Investing Activities	-$105.1M	-$33.89M
Cash From Financing Activities	$248.2M	$294.0M
Net Change In Cash	$126.2M	$239.5M
YoY Change	-47.32%	7994.29%
FREE CASH FLOW
Cash From Operating Activities	-$16.92M	-$20.57M
Capital Expenditures	-$52.18M	-$33.89M
Free Cash Flow	$35.25M	$13.32M
YoY Change	164.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001830033
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Business Days Prior To Notice Of Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodBusinessDaysPriorToNoticeOfRedemption	P3D
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-40234
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32822
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	PureCycle Technologies, Inc.
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-2293091
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5950 Hazeltine National Drive,
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 650
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q1	dei	City Area Code CityAreaCode	877
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	648-3565
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	163232226	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	198169000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33417000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	219759000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	USD
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	100210000	USD
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	141855000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3191000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2712000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	521329000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	345349000	USD
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	91663000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	88586000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	5524000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	5535000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13953000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2022Q1	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	55876000	USD
CY2021Q4	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	6113000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	266305000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	225214000	USD
CY2022Q1	us-gaap	Assets Assets	898774000	USD
CY2021Q4	us-gaap	Assets Assets	664684000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1841000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1401000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19330000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35526000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	6127000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1532000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	27298000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38459000	USD
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5000000	USD
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5000000	USD
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	232752000	USD
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	232508000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13561000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1106000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1069000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	335593000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	283149000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163234000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163234000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127647000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127647000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	163000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	128000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	547000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	746806000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	539423000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-577000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-237000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183211000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157779000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	563181000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	898774000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	664684000	USD
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4048000	USD
CY2021Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2130000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	339000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14747000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7624000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	19134000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	10301000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	444000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2043000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5835000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	13621000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-109000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6298000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15773000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25432000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26074000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133244000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133244000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51223000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51223000	shares
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-340000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25772000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26074000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	205296000	USD
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1049000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3171000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-340000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25432000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	563181000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	111749000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	239000	USD
CY2021Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	36000	USD
CY2021Q1	pct	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	28000000	USD
CY2021Q1	pct	Stock Issued During Period Value Reverse Recapitalization Net Of Redemptions And Issuance Costs StockIssuedDuringPeriodValueReverseRecapitalizationNetOfRedemptionsAndIssuanceCosts	293966000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0	USD
CY2021Q1	pct	Stock Reclassified During Period Value StockReclassifiedDuringPeriodValue	33000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	68000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26074000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	349241000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25432000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26074000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3171000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	307000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	5835000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	13621000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	818000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	490000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	244000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	841000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-146000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	287000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	USD
CY2022Q1	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	0	USD
CY2021Q1	pct	Issuance Of Warrants Costs IssuanceOfWarrantsCosts	109000	USD
CY2022Q1	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	479000	USD
CY2021Q1	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	1770000	USD
CY2022Q1	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	-11000	USD
CY2021Q1	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	1685000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	747000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	423000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2503000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-13037000	USD
CY2022Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	324000	USD
CY2021Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1207000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5000000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-93000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16924000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20568000	USD
CY2022Q1	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	52177000	USD
CY2021Q1	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	33891000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	98070000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2021Q1	pct	Business Combination Acquisition Related Costs General And Administrative BusinessCombinationAcquisitionRelatedCostsGeneralAndAdministrative	3200000	USD
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	45189000	USD
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105058000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33891000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	206071000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	43929000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1049000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	775000	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-10000	USD
CY2021Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	55000	USD
CY2022Q1	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
CY2021Q1	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	USD
CY2022Q1	pct	Payments Of Notes Issuance Costs PaymentsOfNotesIssuanceCosts	0	USD
CY2021Q1	pct	Payments Of Notes Issuance Costs PaymentsOfNotesIssuanceCosts	4067000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	480000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248166000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	293969000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	126184000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	239510000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263858000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	330574000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	390042000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	570084000	USD
CY2022Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	13918000	USD
CY2021Q1	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	16437000	USD
CY2022Q1	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	329000	USD
CY2021Q1	pct	Construction In Progress Expenditures Accrued For But Not Yet Paid ConstructionInProgressExpendituresAccruedForButNotYetPaid	0	USD
CY2022Q1	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	4271000	USD
CY2021Q1	pct	Construction In Progress Expenditures Owed But Not Yet Paid ConstructionInProgressExpendituresOwedButNotYetPaid	4270000	USD
CY2022Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2021Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4604000	USD
CY2021Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	25000000	shares
CY2021Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	250000000	USD
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares Maximum Issued DerivativeInstrumentContingentConsiderationLiabilitySharesMaximumIssued	4000000	shares
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriod	P6M
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	D
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	D
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157800000	USD
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Adjustments To Additional Paid In Capital Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalRecapitalizationTransactionCosts	27900000	USD
CY2021Q1	pct	Business Combination Acquisition Related Costs Advisory Legal And Accounting BusinessCombinationAcquisitionRelatedCostsAdvisoryLegalAndAccounting	5200000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Net ReverseRecapitalizationMergerConsiderationNet	1156900000	USD
CY2021Q1	pct	Reverse Recapitalization Number Of Shares Transferred In Merger ReverseRecapitalizationNumberOfSharesTransferredInMerger	83500000	shares
CY2021Q1	pct	Reverse Recapitalization Shares Transferred In Merger Price Per Share ReverseRecapitalizationSharesTransferredInMergerPricePerShare	10.00
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Transferred ReverseRecapitalizationMergerConsiderationTransferred	835000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Revenue Bonds ReverseRecapitalizationMergerConsiderationRevenueBonds	249600000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Convertible Notes ReverseRecapitalizationMergerConsiderationConvertibleNotes	60000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Line Of Credit ReverseRecapitalizationMergerConsiderationLineOfCredit	314000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Related Party Promissory Note ReverseRecapitalizationMergerConsiderationRelatedPartyPromissoryNote	12000000	USD
CY2021Q1	pct	Reverse Recapitalization Merger Consideration Net ReverseRecapitalizationMergerConsiderationNet	1156914000	USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	pct	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	76510000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000000	USD
CY2021Q1	pct	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	28049000	USD
CY2021Q1	pct	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	298461000	USD
CY2021Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4600000	USD
CY2022Q1	pct	Business Combination Acquisition Related Costs Advisory Legal And Accounting BusinessCombinationAcquisitionRelatedCostsAdvisoryLegalAndAccounting	800000	USD
CY2022Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in prior periods have been reclassified to conform with the report classifications of the three months ended March 31, 2022 and 2021.</span></div>
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	198200000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33400000	USD
CY2022Q1	pct	Working Capital WorkingCapital	494000000	USD
CY2021Q4	pct	Working Capital WorkingCapital	306900000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-183200000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25400000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-26100000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q1	pct	Common Stock Number Of Votes For Each Share Held CommonStockNumberOfVotesForEachShareHeld	1	vote
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163230000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163230000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127650000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127650000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	613000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	28900
CY2021Q1	pct	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P7Y
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M15D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28900
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M18D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	613000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.41
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	pct	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2021Q1	pct	Class Of Warrant Or Right Redemption Of Warrants Or Rights Written Notice Of Redemption Threshold ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsWrittenNoticeOfRedemptionThreshold	P30D
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Stock Price Trigger DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Days DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	D
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Threshold Trading Day Period DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	D
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25432000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-25432000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26074000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-26074000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133244000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	133244000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51223000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	51223000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.19
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.19
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.51
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.51
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	272191000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5886000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	266305000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	230295000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5081000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	225214000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	818000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	490000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	220336000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	583000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	219759000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	167602000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	237000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	180970000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	180711000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	117164000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	117100000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	39366000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	39048000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	50438000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	50265000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	220336000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	219759000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	167602000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167365000	USD
CY2022Q1	pct	Debt Securities Held To Maturity Weighted Average Remaining Maturity DebtSecuritiesHeldToMaturityWeightedAverageRemainingMaturity	P0Y6M
CY2022Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2021Q2	pct	Loss Contingency Number Of Class Actions LossContingencyNumberOfClassActions	2	classAction
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12300000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	12700000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	423000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	103000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	526000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	230000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1943000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M24D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13953000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1012000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13561000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	14573000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1119000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1824000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1867000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1918000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1836000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1856000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7391000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	17811000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3238000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	14573000	USD

Files In Submission

Name	View Source	Status
0001830033-22-000028-index-headers.html	Edgar Link	pending
0001830033-22-000028-index.html	Edgar Link	pending
0001830033-22-000028.txt	Edgar Link	pending
0001830033-22-000028-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pct-20220331.htm	Edgar Link	pending
pct-20220331.xsd	Edgar Link	pending
pct-20220331_cal.xml	Edgar Link	unprocessable
pct-20220331_def.xml	Edgar Link	unprocessable
pct-20220331_g1.jpg	Edgar Link	pending
pct-20220331_htm.xml	Edgar Link	completed
pct-20220331_lab.xml	Edgar Link	unprocessable
pct-20220331_pre.xml	Edgar Link	unprocessable
pct-form10xqex311q12022.htm	Edgar Link	pending
pct-form10xqex312q12022.htm	Edgar Link	pending
pct-form10xqex321q12022.htm	Edgar Link	pending
pct-form10xqex322q12022.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCT
PureCycle Technologies, Inc. Stock $pct

2022 Q1 Form 10-Q Financial Statement

#000183003322000028 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT PureCycle Technologies, Inc. Stock $pct

2022 Q1 Form 10-Q Financial Statement

#000183003322000028 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT
PureCycle Technologies, Inc. Stock $pct